Haemonetics Corp. said Monday net income slid 5 percent in its first fiscal quarter, dragged down by a product recall. The maker of blood collection and processing systems also lowered its earnings expectations for fiscal 2012.
Boston Globe
Mon, 08/01/2011 - 9:58am
Haemonetics Corp. said Monday net income slid 5 percent in its first fiscal quarter, dragged down by a product recall. The maker of blood collection and processing systems also lowered its earnings expectations for fiscal 2012.